Journal

Stem cells: when they apply and when they do not

Stem cell treatment has precise indications and clear exclusion criteria. Here we explain how the decision is made and whether it applies to your case.

Longevia MedicalNovember 13, 2026Leer en español

A therapy guided by clinical judgment, not enthusiasm

Stem cell treatment raises expectations that often exceed what current evidence supports. Before discussing candidacy, one point must be established: when stem cells apply is not a question with a single answer, because the answer depends on the diagnosis, the person's overall condition, the stage of the condition, and the intended goal.

Enthusiasm is not a clinical criterion. Assessment is.

What the evidence supports today

The field of stem cells has areas with established clinical backing, areas under active investigation, and areas where application is not justified. Distinguishing among these three categories is the foundation of any honest clinical conversation.

What is accepted: the use of stem cells in certain hematological disorders and in bone marrow transplant settings has decades of documented clinical experience. In these cases, the indication is established by the specialist managing the underlying condition, not by a regenerative medicine clinic.

What remains under study: applications in regenerative medicine for joint, metabolic, autoimmune, and cellular aging conditions are actively being investigated. There are signals of clinical interest, but protocols, doses, frequency, and ideal candidate profiles are still being defined. To say otherwise would be imprecise.

What does not apply: stem cells do not cure established chronic diseases, do not reverse severe organ damage, and do not replace foundational medical treatment. Anyone seeking a cure will encounter disappointment; anyone seeking support for a regenerative process, with clinical judgment, may, in some cases, find an indication.

The smallest intervention that responsibly addresses the objective is always the first option. Stem cells are not the answer to everything, and knowing that is the starting point of an honest assessment.

Stem cells when they apply: general candidacy criteria

Candidacy for stem cell treatment is determined by the combination of four factors. No single factor is sufficient on its own: all four are evaluated together during the assessment.

Confirmed diagnosis

A general sense of decline or the desire to "rejuvenate" are not diagnoses. For an assessment to be meaningful, the person must arrive with a documented diagnosis or recent studies that allow one to be established. Treatment is oriented toward a specific condition, not toward an aspiration.

Stage of the condition

Stage matters more than is commonly recognized. In conditions where damage is already structural and irreversible, stem cells do not rebuild what has been lost. The indication tends to be more relevant when the process is still active and there is functional tissue to support, not when deterioration has already run its course.

Overall health status

The response to treatment depends, in large part, on the state of the organism receiving it. A person with uncontrolled systemic inflammation, active infection, severe immunosuppression, or an active oncological condition is not a candidate. Not because the treatment is abstractly dangerous, but because the biological environment does not support the response being sought.

Calibrated expectations

This criterion is not minor. A person who expects outcomes that the evidence does not support is not a suitable candidate, regardless of their diagnosis. The assessment includes a conversation about what can and cannot be expected, and that dialogue is part of the protocol.

Does age alone decide?

No. A forty-year-old with severe organ damage may be a worse candidate than a sixty-five-year-old with good metabolic status and a controlled condition. Biological age, biomarkers, and functional status carry more weight than the number on an identity document. The question what age is stem cell treatment for? has no answer by age range: it has an answer by individual assessment.

When stem cell treatment is not the indication

There are conditions in which the assessment leads to the conclusion that treatment does not apply. Recognizing them clearly is part of clinical judgment, not a limitation of the service.

  • Active or ongoing oncological condition: the cellular proliferation the treatment seeks to promote may interact in unintended ways with an active tumor process. This contraindication is firm.
  • Active infection or sepsis: the systemic inflammatory environment that accompanies an infection is not compatible with the regenerative response being sought.
  • Severe immunosuppression: when the immune system is significantly compromised, the response to treatment is unpredictable and the risk outweighs the potential benefit.
  • Active-phase autoimmune condition without control: an autoimmune disease in active flare requires stabilization first; regenerative therapy, if it ever takes place, comes after and with input from the rheumatologist or managing specialist.
  • Terminal or irreversible organ damage: when an organ has permanently lost its function, there is no residual tissue on which to build a regenerative response.
  • Expectations of cure or definitive resolution: if the person is seeking a cure, the honest answer is that no one can promise that. That gap between expectation and evidence is itself a signal that the assessment must pause at the conversation before going further.
Saying it does not apply is not a rejection: it is the same clinical judgment that determines when it does. An assessment that only accepts candidates is not an assessment.

How the decision is made in your case: the assessment ahead of the visit

The decision to travel to Cancún for stem cell treatment should come after the assessment, not before. That is the correct clinical order, and it protects the patient from an unnecessary trip or misaligned expectations.

At Longevia Medical, located in Puerto Cancún, care begins with an assessment that can be in-person or remote. The remote assessment allows us to review the diagnosis, available studies, overall condition, and expectations before the person makes any travel decision. The plan, when there is an indication, is delivered in writing and is individual.

Follow-up does not end when the patient returns home. Medical supervision continues in a coordinated manner, and that is part of the protocol from the outset.

For the assessment to be productive, it is helpful to arrive with recent studies: complete blood count, metabolic panel, hepatic and renal profile, and any imaging or reports from the specialist managing the underlying condition. These are not a requirement to request the assessment, but they do sharpen the clinical conversation from the start.

flowchart TD
    A["Person interested in stem cell treatment"] --> B["Remote or in-person assessment"]
    B --> C["Review of diagnosis, studies, and overall condition"]
    C --> D{"Is there an indication?"}
    D -->|"Yes"| E["Individual written plan"]
    D -->|"No"| F["Explanation of why it does not apply and what alternatives exist"]
    E --> G["Protocol with medical supervision"]
    G --> H["Follow-up after returning home"]

What to consider before requesting an assessment

There are questions worth asking before contacting any regenerative medicine clinic, not only Longevia Medical. These questions are not a selection filter: they are the minimum exercise of someone making decisions with judgment.

  • Do I have a documented diagnosis, or only diffuse symptoms?
  • Is my condition at a stage where functional tissue can still receive support?
  • Is my overall condition, including inflammation, renal and hepatic function, in a state to respond to regenerative treatment?
  • Are my expectations aligned with what current evidence supports, not with what I would like to be possible?
  • Am I available for follow-up, not only for the initial treatment?

If the answer to any of these questions opens more uncertainty than clarity, that is precisely the moment for an assessment, not a reason to postpone it.

To understand in greater depth what the body does with these cells and what the current limits of their application are, the article on what stem cells are used for, with their evidence and limits addresses that point in detail. If your interest is in evaluating a clinic before making a decision, the article on how to evaluate a stem cell therapy clinic in Mexico provides practical criteria for that process.

Candidacy is not decided by enthusiasm or by age. It is decided by diagnosis, overall condition, stage of the condition, and calibrated expectations. Those four factors together are the only honest answer to when stem cell treatment applies.

Frequently asked questions

When do stem cells apply in adults over 60?

Age alone does not determine candidacy. What is evaluated is biological status: biomarkers, underlying condition, stage of the process, and expectations. A person over sixty with good organ function may be a candidate; a forty-year-old with severe damage may not be.

When is stem cell treatment a real option and when is it not?

It is an option to evaluate when there is a documented diagnosis, functional tissue to support, a compatible overall condition, and expectations aligned with the evidence. It does not apply in active oncological conditions, infection, severe immunosuppression, or irreversible organ damage.

Can I know whether I am a candidate before traveling to Cancún?

Yes. The assessment can be conducted remotely, reviewing the diagnosis, recent studies, and overall condition. If there is an indication, the plan is delivered in writing before any travel takes place. The trip comes after the assessment, never before.

Do stem cells cure chronic diseases?

No. Stem cells do not cure established chronic diseases or reverse permanent organ damage. Their application, when indicated, seeks to support active regenerative processes. No one can promise a result, and any clinic that does merits critical scrutiny.

What studies should I bring to a stem cell assessment?

It is helpful to arrive with a complete blood count, metabolic panel, hepatic and renal profile, and any report from the specialist managing the underlying condition. These are not a requirement to request the assessment, but they allow the clinical conversation to be more precise from the start.

For general reading on stem cells and regenerative therapies, Mayo Clinic and MedlinePlus offer patient-oriented information in accessible terms and without commercial conflict of interest.

Begin privately

Tell us what you want to protect.

This first conversation is for orientation, not diagnosis. A coordinator will identify the right clinical pathway and explain the secure next step.

Request a private consultation↗

Book a private consultation

Tell us what you want to protect.

Choose a preferred date and time. A coordinator confirms your appointment by WhatsApp or email and explains the secure next step. This first conversation is for orientation, not diagnosis.

Do not include medical records or sensitive health information here.
Thank you. We received your request. A coordinator will confirm your appointment by WhatsApp or email.